A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy.
about
Antiepileptic drug monotherapy for epilepsy: a network meta-analysisOxcarbazepine for neuropathic painOxcarbazepine versus phenytoin monotherapy for epilepsyOxcarbazepine versus carbamazepine monotherapy for partial onset seizuresOxcarbazepine for neuropathic painComparative monotherapy trials and the clinical treatment of epilepsyEpidemiology, pathophysiology and putative genetic basis of carbamazepine- and oxcarbazepine-induced hyponatremia.The promise of new antiepileptic drugs.Suppressive effects of oxcarbazepine on tooth pulp-evoked potentials recorded at the trigeminal spinal tract nucleus in cats.Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.Monostars: an aid to choosing an antiepileptic drug as monotherapy.Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs.Oxcarbazepine.Predictive value of lidocaine for treatment success of oxcarbazepine in patients with neuropathic pain syndromeNew generation antiepileptic drugs: what do they offer in terms of improved tolerability and safety?Safety and efficacy of oxcarbazepine: results of randomized, double-blind trials.Current discoveries on the cognitive effects of antiepileptic drugs.Treatment of epilepsy in the multiply handicapped.Strategies for optimizing antiepileptic drug therapy in elderly people.New anti-epileptic drugs for the 21st century.Beneficial and adverse psychotropic effects of antiepileptic drugs in patients with epilepsy: a summary of prevalence, underlying mechanisms and data limitations.The management of refractory idiopathic epilepsies.A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients.Carbamazepine-hypersensitivity: assessment of clinical and in vitro chemical cross-reactivity with phenytoin and oxcarbazepine.Recommendations on the clinical use of oxcarbazepine in the treatment of epilepsy: a consensus view.Oxcarbazepine in the treatment of epilepsy.Appropriate use of medications for seizures. Guiding principles on the path of efficacy.Effects of oxcarbazepine on sodium concentration and water handling.Second generation anticonvulsant medications: their use in children.What can we learn from clinical trials of anticonvulsant drugs in epilepsy?Three new drugs for epilepsy: levetiracetam, oxcarbazepine, and zonisamide.Using the new antiepilepsy drugs in children.The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial.Economics in epilepsy treatment choices: our certain fate?Novel anticonvulsant medications in development.Treatment of epilepsy in China: Formal or informal.Safety and tolerability of emerging pharmacological treatments for bipolar disorder.Efficacy and safety of oxcarbazepine in the treatment of children with epilepsy: a meta-analysis of randomized controlled trialsAntiepileptic drug treatment in children.Oxcarbazepine in neuropathic pain.
P2860
Q24187678-E534038A-79A7-4510-B2E7-D7320A71B1E1Q24198916-248F4699-9A0C-444C-8C06-5DB6FC8E685CQ24202768-118DD083-486A-4612-95E6-434624F648FFQ24239996-0FEEF9B2-33BF-48C5-984D-F67C67C9ECA1Q24240708-180A083A-A2C2-426F-9515-A4491A8879B0Q24673196-A23774B5-37B4-4472-BD50-4A0A73AE68CBQ30249421-AE9C8265-EDC9-48D0-B8E3-F50A8303A869Q30674774-8C1C19E4-A2D6-4E51-AA5C-9951D86E26E2Q32027306-6835DDE7-1B5E-4F8E-B4C3-B2056D2F4141Q33202108-077476E3-7335-4B32-90F9-89B3812B3C7AQ33756716-4917931D-81C3-4396-8514-7AE7CA517985Q33756749-0590259D-DBFC-4E85-B1CE-A640D85B859EQ33756777-5CB8BFE9-BEE2-4E8D-BB44-9731D75E3740Q33938147-04304C83-7C5B-4FCE-A73E-E0EBD9927B52Q33949491-DC6B7D55-081F-4000-A8E2-97FF97B1F993Q33999456-2AE95A01-1A42-4211-9A8F-03AA93295296Q33999483-C05DEA30-67BC-4C33-B238-1FFAFF29C25CQ34099234-88F8D0C3-F7B1-4CE3-9F3E-5A17D783357AQ34118987-6D2AF406-B3C9-4D27-AEB0-64976FFB49AAQ34182061-6627371C-8213-42A7-B3F4-1EE4C8EE58F8Q34186198-B64C0BAD-B720-46C0-90C9-803D1FAD48D8Q34345026-1573FDA7-2836-4770-ABE1-7FB4FA9A82E0Q34345926-70D4AEFB-27B6-4181-86F8-B5DC97C30CB3Q34358782-60B124CF-D494-4E35-967E-3387A4472DA6Q34364855-ACE162DF-E73B-4A86-B3CB-11DF69102A1FQ34445634-60D19B8D-C9FC-49B2-B66E-B95D3BA1650DQ34505848-EF04DDDE-0870-4DA5-B933-02756F858010Q34525209-29CB78FD-1212-4FF2-948E-BAA94FCCA6CFQ34555652-1745EB09-4972-4E78-97DC-05B3BEC39EA3Q34558531-94CA6CF5-1C0B-461B-B7BE-C2990A1337AEQ34579452-C088AB82-25DB-4085-9FDF-5E1C9075F9E1Q34579459-EF40ABF3-ECFF-46AD-8F5B-18483264DF0AQ34611908-2F339809-7EB5-4AAE-A241-CC6331B49095Q34680666-136A94CE-05B8-4FD1-88DD-78C1CB941169Q34974862-E82A8228-51B9-4FF3-87E7-2E59E0128C6CQ35245431-332EEECC-9FCA-4401-BCCB-F18D38277CADQ36199036-217EAB7B-66C1-4F8B-8F23-0485BA684D87Q36307956-9BB238B0-020E-42A9-B7EC-5DD3941F9970Q36730668-2452A5FA-5D20-4EB0-A8E5-AA7FBF92535BQ36964709-1E7872E7-740B-42A1-9EB5-F5184E87FB80
P2860
A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
A double-blind study comparing ...... previously untreated epilepsy.
@en
A double-blind study comparing ...... previously untreated epilepsy.
@nl
type
label
A double-blind study comparing ...... previously untreated epilepsy.
@en
A double-blind study comparing ...... previously untreated epilepsy.
@nl
prefLabel
A double-blind study comparing ...... previously untreated epilepsy.
@en
A double-blind study comparing ...... previously untreated epilepsy.
@nl
P2093
P1433
P1476
A double-blind study comparing ...... previously untreated epilepsy.
@en
P2093
P356
10.1016/0920-1211(89)90070-3
P577
1989-01-01T00:00:00Z